MEGAN FROILAND: Open Payments
NPI 1194580944 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $455 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $159 |
| Boston Scientific Corporation | 2 | $154 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| PFIZER INC. | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $53 |
| Abbott Laboratories | 3 | $44 |
| GENZYME CORPORATION | 2 | $39 |
| United Therapeutics Corporation | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $22 |
Products named: LEQVIO, WATCHMAN Access System, VYNDAQEL, ONPATTRO, ELIQUIS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FABRAZYME, SAPIEN 3 Ultra RESILIA.
Industry payments across WI — which companies pay providers there.
